Ignacio Aznar Lou
Investigador post-doc
Researcher Ignacio Aznar Lou graduated in Pharmacy in 2014 from the Universidad San Jorge de Zaragoza and obtained his PhD in Pharmacy from the University of Barcelona in 2017.
In recent years he has carried out postdoctoral stays at Southern Denmark University (Denmark) and the University of Lisbon, where he studied various techniques for assessing population drug use and evidence review.
He is currently working on several projects related to the analysis of large real world databases in the fields of pharmacoepidemiology and pharmacoeconomics.
Professional network profiles
Last Publications
- Alba-Palé L, Besoaín AM, Latorre Martínez S, Ortiz Valen S, Coll Gomila MC, Pérez Garcia H, Alonso Varela L, Sáez Dolado S, Zubero Ramírez E, Alouali Moussakhkhar M, Baladon L, Aznar I and Serrano-Blanco A Effectiveness of a Crisis Resolution and Home Treatment Program for the Acute Treatment of Severe Mental Illness INTERNATIONAL JOURNAL OF SOCIAL PSYCHIATRY . : .
- Mucherino S, Raimondo A, Krstin M, Aznar I, Serino M, Perrella L, Bernardi FF, Trama U, Menditto E, Lembo S and Orlando V Drug Utilization and Medication Adherence: A Data-Driven Analysis of Drugs with Different Routes of Administration Applied in Atopic Dermatitis. Pharmaceutics . 17(10): .
- Soler M, Aznar I, Almansa J, Peña P, Silva-Peñaherrera M, Serra C and Ramada JM Cost-Effectiveness of a Multi-faceted Workplace Intervention to Reduce Musculoskeletal Pain in Nursing Staff: A Cluster-Randomized Controlled Trial (INTEVAL_Spain) JOURNAL OF OCCUPATIONAL REHABILITATION . 35(3): 602-614.
Projects
- Project name:
- M-AES_Estancia en Center of Research in Pharmacoeconomics and Drug utilization (CIRFF) at University of Naples Federico Il
- Leader
- Ignacio Aznar Lou
- Funding entities:
- Instituto de Salud Carlos III (ISCIII)
- Code
- MV23/00027
- Starting - finishing date:
- 2024 - 2024
- Project name:
- SALVOVAR : A EUROPEAN MULTI-DISCIPLINARY CLINICAL PROJECT MEANT TO IMPROVE THE MANAGEMENT OF PATIENTS WITH POOR PROGNOSTIC OVARIAN CANCER AFTER NEOADJUVANT CHEMOTHERAPY: RESTORING HOPE, SALVAGING LIVES
- Leader
- Alexandra Lelia Dima
- Funding entities:
- European Commission
- Code
- 101104469
- Starting - finishing date:
- 2023 - 2028
- Project name:
- Miguel Servet (Contrato)
- Leader
- Ignacio Aznar Lou
- Funding entities:
- Instituto de Salud Carlos III (ISCIII)
- Code
- CP22/00029
- Starting - finishing date:
- 2023 - 2027
News
-
Dementia cases could triple by 2050 if countries do not address the risk factors
According to a study published in The Lancet Public Health, the number of people with dementia could triple by 2050. This study is conducted by an international research team with the participation of Dr. Ai Koyanagi and Dr. Jacob Louis of Epidemiology of Mental Disorders and Aging from IRSJD.
